文献速递血管炎

肉芽肿性多血管炎:法国血管炎研究组795例患者注册研究

Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry.
PubMed 文献 · Semin Arthritis Rheum · 2021-02-10

基于法国血管炎研究组数据库纳入795例新诊断肉芽肿性多血管炎(GPA)患者,中位随访3.5年,描述临床特征与长期结局。5年和10年无复发生存率分别为37%和17%,PR3-ANCA阳性独立预测复发与生存改善,2000年后诊断患者10年总生存达88.2%。

要点

  • GPA初诊常累及耳鼻喉(80%)、肺(68%)和肾(56%),PR3-ANCA阳性占75.0%。
  • 复发率高,5年和10年无复发生存率仅37%和17%。
  • PR3-ANCA阳性与复发风险增加及生存改善独立相关。

核心结论

  • 过去数十年GPA生存率显著改善,但高复发率仍是主要问题,需优化治疗策略以降低复发。
  • PR3-ANCA阳性与复发概率增加及生存改善相关。

研究设计与样本

  • 基于法国血管炎研究组数据库纳入795例新诊断GPA患者,中位随访3.5年,分析临床特征、BVAS活动度、恶性肿瘤、机会性感染及生存状态。
  • 采用Cox回归分析总生存(OS)和无复发生存(RFS)的估计概率及预测因素。

主要发现

  • 初诊临床表现累及耳鼻喉80%、肺68%、肾56%。
  • 728例可用的ELISA结果中,PR3-ANCA阳性75.0%,MPO-ANCA阳性16.5%,ANCA阴性62例(8.5%)。
  • 394例(50%)发生复发,其中179例(46%)累及至少1个初诊受累器官,主要为耳鼻喉、肺和肾,平均BVAS较诊断时低10.2分(p<0.001)。
  • 5年和10年RFS率分别为37%和17%。
  • PR3-ANCA阳性独立预测复发(p=0.05)和生存延长(p=0.038);OS(而非RFS)随时间显著改善(p<0.001),2000年后诊断的660例患者10年OS达88.2%(95%CI 83.9至92.7)。

关键数值与推荐

  • 5年无复发生存率37%,10年无复发生存率17%。
  • 2000年后诊断的660例患者10年总生存率88.2%(95%CI 83.9至92.7)。
  • PR3-ANCA阳性预测复发p=0.05,预测生存延长p=0.038。

临床怎么用

  • GPA患者初诊应评估耳鼻喉、肺和肾受累,并检测ANCA亚型以协助风险分层。
  • PR3-ANCA阳性患者复发风险较高,需加强随访和复发监测。
  • 感染是主要死因,临床管理中应重视感染预防与监测。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the characteristics and long-term outcomes of patients with granulomatosis with polyangiitis (GPA) from the French Vasculitis Study Group database. METHODS: Patients' clinical and laboratory characteristics, Birmingham Vasculitis Activity Score (BVAS)-assessed disease activity, malignancies, opportunistic infections, and vital status were collected at diagnosis and each visit. Estimated probabilities and predictors of overall (OS) and relapse-free survival (RFS) were analyzed by Cox regression. RESULTS: We enrolled 795 newly diagnosed patients, followed for a median of 3.5 years. Initial clinical manifestations involved ear, nose & throat (ENT; 80%), lungs (68%) and kidneys (56%). Among the 728 available ELISA results, 75.0% were PR3-ANCA-positive, 16.5% MPO-ANCA-positive and 62 (8.5%) ANCA-negative. Relapses occurred in 394 (50%) patients, involving ≥1 organ(s) affected at onset in 179 (46%), mainly ENT, lungs and kidneys, with mean BVAS 10.2 points below that at diagnosis (p<0.001). Five- and 10-year RFS rates were 37% and 17%, respectively. PR3-ANCA-positivity independently predicted relapse (p = 0.05) and prolonged survival (p = 0.038). OS-but not RFS-improved significantly over time (p<0.001); 10-year OS reached 88.2% (95% CI 83.9 to 92.7) for the 660 patients diagnosed after 2000. Infections were the main causes of death. Malignancy or opportunistic infection each occurred in ≤5% of the patients. CONCLUSION: Survival has improved dramatically over the last decades but the high relapse rate remains a major concern for GPA patients, once again stressing the need for therapeutic strategy optimization to lower it. PR3-ANCA-positivity was associated with increased probability of relapse and survival.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Iudici M, Pagnoux C, Courvoisier DS, et al. Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registry. Semin Arthritis Rheum. 2021. PMID: 33601189. doi:10.1016/j.semarthrit.2021.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。